Before
This page presents a press release from the Ministry of Health, Labour and Welfare dated January 21, 2022, regarding the special approval of a COVID-19 vaccine. Pfizer's "Comirnaty Intramuscular Injection for Ages 5-11" received special approval under pharmaceutical law. The vaccine is intended to prevent SARS-CoV-2 infection. The administration method involves diluting the vaccine in saline solution and administering two intramuscular injections with a three-week interval between doses.
